9987 logo

Suzuken Co., Ltd. Stock Price

TSE:9987 Community·JP¥343.8b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

9987 Share Price Performance

JP¥0
-5256.00 (-100.00%)
JP¥0
-5256.00 (-100.00%)
Price JP¥0

9987 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Very undervalued with flawless balance sheet and pays a dividend.

2 Risks
5 Rewards

Suzuken Co., Ltd. Key Details

JP¥2.5t

Revenue

JP¥2.3t

Cost of Revenue

JP¥192.5b

Gross Profit

JP¥154.4b

Other Expenses

JP¥38.1b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 07, 2026
563.83
7.74%
1.53%
0%
View Full Analysis

About 9987

Founded
1932
Employees
12923
CEO
Shigeru Asano
WebsiteView website
www.suzuken.co.jp

Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the distribution of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution, Healthcare Product Development, Community Healthcare and Nursing Care Support, and Healthcare Related Services. The Pharmaceutical Distribution Business segment purchases ethical drugs, diagnostic agents, medical equipment, medical materials, and medical food products, as well as pharmaceutical and medical equipment manufacturers, and supplies medical institutions, and insurance pharmacies. The Healthcare Product Development segment offers ethical drugs, diagnostic reagents, and medical devices and materials. The Community Healthcare and Nursing Care Support segment provides a range of pharmacy and nursing care services. The Healthcare Related Services segment offers contract distribution for manufacturers and contract distribution of orphan drugs. Suzuken Co., Ltd. was founded in 1932 and is headquartered in Nagoya, Japan.